Dell Medical School presents: Wilson Sonsini Goodrich & Rosati Healthcare Innovations Venture Investment Forum
On December 6, 7, and 8, 2017, The University of Texas in Austin’s Dell Medical School will present and co-host the Wilson Sonsini Goodrich & Rosati’s third Healthcare Innovations Venture Investment Forum. Each of the participating investors will separately review company submissions and select the companies with which they would like to meet. Companies selected for a meeting with any investor during the Forum will have the opportunity to privately meet with the investor for about 40 minutes.
Confirmed Investors Meeting Companies in Person:
3M Ventures, 5AM Ventures, AbbVie Biotech Ventures, Apple Tree Partners, Atlas Venture, ARCH Venture Partners, Bain Capital, Bay City Capital, Deerfield, Gurnet Point Capital, HIG Capital, Illumina Ventures, J&J Innovations, Lilly Ventures, Merck Global Health Innovation Fund, NEA, Novartis Institutes for Biomedical Research, Novo Ventures, Pfizer, Inc., RA Capital, Sailing Capital, Siemens Healthineers, SR One, Taiho Ventures, 8VC, Accelerator Corp., Ajax Health, Apex Landmark, Cartmell VC, Charles River Ventures, Civilization Ventures, Hatteras Venture Partners, Integra LifeSciences Holdings, KdT Ventures, Live Oak Venture Partners, Mercury Fund, MP Healthcare Venture Management, PTV Healthcare, S3 Ventures, Santé Ventures, Thiel Capital, Translink Capital Partners, and True Wealth Ventures.